-
eMERGE Network's Multi-Center Pilot of Pharmacogenetic Sequencing in Clinical Practice
Study
phs000906
-
National Cancer Institute (NCI) TARGET: Therapeutically Applicable Research to Generate Effective Treatments
Study
phs000218
-
Single Cell Analysis Program - Transcriptome (SCAP-T)
Study
phs000833
-
T2D-GENES Project 2: San Antonio Mexican American Family Studies
Study
phs000462
-
Systolic Blood Pressure Intervention Trial (SPRINT-BioLINCC)
Study
phs003483
-
Systolic Blood Pressure Intervention Trial (SPRINT-Imaging)
Study
phs003566
-
Cincinnati Children's Hospital Medical Center (CCHMC) - eMERGE Phase IIIA Data
Study
phs001011
-
New England-Based Case-Control Study of Ovarian Cancer
Study
phs001034
-
Neoantigen-Targeted CD8+ T-Cell Responses 1 With PD-1 Blockade Therapy
Study
phs003153
-
National Epidemiologic Survey on Alcohol and Related Conditions-III (NESARC-III)
Study
phs001590